EA
IDXX icon

Emerald Acquisition’s Idexx Laboratories IDXX Stock Holding History

Emerald Acquisition’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$16.3M Sell
144,799
-23,805
-14% -$2.51M 0.03% 623
2016
Q2 		$15.7M Buy
+168,604
New +$14.5M 0.03% 692

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Emerald Acquisition's IDXX Position: Q3 2016 in Review

Emerald Acquisition reduced its Idexx Laboratories (IDXX) stake by 14% in Q3 2016, selling an estimated $2.51M and leaving 144,799 shares worth $16.3M. The position accounts for 0.03% of the portfolio, ranked #623.

Emerald Acquisition first reported a position in IDXX in Q2 2016 and has held it in 2 quarters since. 482 funds tracked by Wall St. Rank hold IDXX as of Q3 2016.

  • Emerald Acquisition held 144,799 shares of Idexx Laboratories worth $16.3M as of Q3 2016.
  • Emerald Acquisition sold 23,805 Idexx Laboratories shares in Q3 2016, an estimated $2.51M.
  • Idexx Laboratories made up 0.03% of Emerald Acquisition's portfolio in Q3 2016, its #623 holding.
  • Emerald Acquisition first reported a position in Idexx Laboratories in Q2 2016 and has held it in 2 quarters since.
  • 482 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.